Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

2.36
-0.0400-1.67%
Post-market: 2.360.00000.00%17:16 EDT
Volume:262.01K
Turnover:634.21K
Market Cap:81.86M
PE:-1.90
High:2.48
Open:2.39
Low:2.36
Close:2.40
Loading ...

Achieve Life Sciences Inc - FDA Agrees on Phase 3 Study Design for Cytisinicline Vaping Cessation

THOMSON REUTERS
·
03 Dec 2024

Achieve Life Sciences Inc - FDA Aligns With Achieve on Phase 3 Study Design for Vaping Cessation

THOMSON REUTERS
·
03 Dec 2024

Achieve Life Sciences Inc - Expects to File Nda for Smoking Cessation in Q2 2025

THOMSON REUTERS
·
03 Dec 2024

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting With FDA

THOMSON REUTERS
·
03 Dec 2024

Achieve Life Sciences Inc - FDA Accepts Single Phase 3 Trial for Vaping Cessation Indication

THOMSON REUTERS
·
03 Dec 2024

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

GlobeNewswire
·
03 Dec 2024

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire
·
14 Nov 2024

Achieve Life Sciences Initiated at Buy by Rodman & Renshaw

Dow Jones
·
14 Nov 2024

ACHV: Commercialization in Focus

Zacks Small Cap Research
·
11 Nov 2024

Achieve Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024

Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
09 Nov 2024

Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)

TIPRANKS
·
08 Nov 2024

Achieve Life Sciences Inc Files for Offering of up to 3.5 Mln Common Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
08 Nov 2024

Achieve Life Sciences Q3 2024 GAAP EPS $(0.36) Misses $(0.26) Estimate

Benzinga
·
08 Nov 2024

Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

GlobeNewswire
·
08 Nov 2024

Achieve Life Sciences Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
06 Nov 2024